Roanna J Hall1,2, Leiv Otto Watne3,4, Emma Cunningham5, Henrik Zetterberg6,7,8, Susan D Shenkin1,2, Torgeir Bruun Wyller3,9, Alasdair M J MacLullich1,2. 1. Edinburgh Delirium Research Group, Geriatric Medicine, University of Edinburgh, Edinburgh, UK. 2. Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, Scotland. 3. Oslo Delirium Research Group, Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway. 4. Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. 5. Centre for Public Health, Queen's University of Belfast, Belfast, Ireland. 6. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. 7. Department of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. 8. Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. 9. Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Abstract
OBJECTIVE: In recent years, there has been a blossoming of studies examining cerebrospinal fluid (CSF) as a method of studying the pathophysiology of delirium. We systematically reviewed the literature for CSF studies in delirium and provide here a summary of the implications for our understanding of delirium pathophysiology. We also summarise the methods used for CSF analysis and discuss challenges and implications for future studies. METHODS: In this systematic review, we screened MEDLINE, EMBASE, PsycINFO, Web of Science, PubMed and the Cochrane Library for articles on CSF biomarkers in delirium, published on 3 September 2016. Studies were required to use Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases criteria for delirium or a validated tool. We excluded case reports. There were no other restrictions on study type. RESULTS: We identified 3280 articles from our initial search, and 22 articles were included in this review. All studies were prospective, including over 400 patients with delirium and 700 controls. More than 70 different biomarkers were studied. Studies could not be compared with each other for meta-analysis because of their heterogeneity and varied widely in their risk of bias and quality assessments. CONCLUSIONS: The 22 studies identified in this review reveal a small but growing literature, in which many of the important hypotheses in delirium pathogenesis have been examined, but from which few firm conclusions can currently be drawn. Nevertheless, the overall interpretation of the literature supports the vulnerable brain concept, that is, that biomarker evidence of, for example, Alzheimer's disease pathology and/or neuroinflammation, is associated with delirium.
OBJECTIVE: In recent years, there has been a blossoming of studies examining cerebrospinal fluid (CSF) as a method of studying the pathophysiology of delirium. We systematically reviewed the literature for CSF studies in delirium and provide here a summary of the implications for our understanding of delirium pathophysiology. We also summarise the methods used for CSF analysis and discuss challenges and implications for future studies. METHODS: In this systematic review, we screened MEDLINE, EMBASE, PsycINFO, Web of Science, PubMed and the Cochrane Library for articles on CSF biomarkers in delirium, published on 3 September 2016. Studies were required to use Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases criteria for delirium or a validated tool. We excluded case reports. There were no other restrictions on study type. RESULTS: We identified 3280 articles from our initial search, and 22 articles were included in this review. All studies were prospective, including over 400 patients with delirium and 700 controls. More than 70 different biomarkers were studied. Studies could not be compared with each other for meta-analysis because of their heterogeneity and varied widely in their risk of bias and quality assessments. CONCLUSIONS: The 22 studies identified in this review reveal a small but growing literature, in which many of the important hypotheses in delirium pathogenesis have been examined, but from which few firm conclusions can currently be drawn. Nevertheless, the overall interpretation of the literature supports the vulnerable brain concept, that is, that biomarker evidence of, for example, Alzheimer's disease pathology and/or neuroinflammation, is associated with delirium.
Authors: Miles Berger; Deborah Oyeyemi; Mobolaji O Olurinde; Heather E Whitson; Kent J Weinhold; Marty G Woldorff; Lewis A Lipsitz; Eugene Moretti; Charles M Giattino; Kenneth C Roberts; Junhong Zhou; Thomas Bunning; Michael Ferrandino; Randall P Scheri; Mary Cooter; Cliburn Chan; Roberto Cabeza; Jeffrey N Browndyke; David M Murdoch; Michael J Devinney; Leslie M Shaw; Harvey Jay Cohen; Joseph P Mathew Journal: J Am Geriatr Soc Date: 2019-01-23 Impact factor: 5.562
Authors: Jennifer Taylor; Margaret Parker; Cameron P Casey; Sean Tanabe; David Kunkel; Cameron Rivera; Henrik Zetterberg; Kaj Blennow; Robert A Pearce; Richard C Lennertz; Robert D Sanders Journal: Br J Anaesth Date: 2022-02-08 Impact factor: 11.719
Authors: Christopher R Carpenter; Nada Hammouda; Elizabeth A Linton; Michelle Doering; Ugochi K Ohuabunwa; Kelly J Ko; William W Hung; Manish N Shah; Lee A Lindquist; Kevin Biese; Daniel Wei; Libby Hoy; Lori Nerbonne; Ula Hwang; Scott M Dresden Journal: Acad Emerg Med Date: 2020-12-12 Impact factor: 5.221
Authors: Jo Ellen Wilson; Matthew F Mart; Colm Cunningham; Yahya Shehabi; Timothy D Girard; Alasdair M J MacLullich; Arjen J C Slooter; E Wesley Ely Journal: Nat Rev Dis Primers Date: 2020-11-12 Impact factor: 65.038
Authors: John Kealy; Carol Murray; Eadaoin W Griffin; Ana Belen Lopez-Rodriguez; Dáire Healy; Lucas Silva Tortorelli; John P Lowry; Leiv Otto Watne; Colm Cunningham Journal: J Neurosci Date: 2020-06-08 Impact factor: 6.167
Authors: Esther S Oh; Oluwaseun Akeju; Michael S Avidan; Colm Cunningham; Kathleen M Hayden; Richard N Jones; Ara S Khachaturian; Babar A Khan; Edward R Marcantonio; Dale M Needham; Karin J Neufeld; Louise Rose; Jessica Spence; Zoë Tieges; Phillip Vlisides; Sharon K Inouye Journal: Alzheimers Dement Date: 2020-04-14 Impact factor: 21.566